Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.
Company profile
Ticker
LCINQ, LCINQ
Exchange
Website
CEO
Timothy Crew
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
NETHERLANDS SECURITIES INC
SEC CIK
Corporate docs
Subsidiaries
Cody Laboratories, Inc. • Silarx Pharmaceuticals, Inc. • Kremers Urban Pharmaceuticals, Inc. ...
IRS number
230787699
LCINQ stock data
Latest filings (excl ownership)
10-Q
2023 Q3
Quarterly report
15 May 23
25-NSE
Exchange delisting
4 May 23
8-K
Lannett Company, Inc. Files Prepackaged Chapter 11 Cases to Significantly Strengthen Financial Position
3 May 23
8-K
In the United States Bankruptcy Court for the District of Delaware
2 May 23
8-K
Lannett Company, Inc. Enters Into Restructuring Support Agreement
1 May 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Apr 23
8-K
Departure of Directors or Certain Officers
14 Apr 23
8-K
LANNETT shares update
4 Apr 23
8-K
Material Modifications to Rights of Security Holders
7 Feb 23
10-Q
2023 Q2
Quarterly report
2 Feb 23
Transcripts
LCINQ
Earnings call transcript
2023 Q2
1 Feb 23
LCINQ
Earnings call transcript
2023 Q1
2 Nov 22
LCINQ
Earnings call transcript
2022 Q4
25 Aug 22
LCINQ
Earnings call transcript
2022 Q3
5 May 22
LCINQ
Earnings call transcript
2022 Q2
4 Feb 22
LCINQ
Earnings call transcript
2022 Q1
4 Nov 21
LCINQ
Earnings call transcript
2021 Q4
26 Aug 21
LCINQ
Earnings call transcript
2021 Q3
6 May 21
LCINQ
Earnings call transcript
2021 Q2
4 Feb 21
LCINQ
Earnings call transcript
2021 Q1
4 Nov 20
Latest ownership filings
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 51.54 mm | 51.54 mm | 51.54 mm | 51.54 mm | 51.54 mm | 51.54 mm |
| Cash burn (monthly) | 3.10 mm | 4.96 mm | 33.81 mm | 21.54 mm | 2.64 mm | 4.79 mm |
| Cash used (since last report) | 6.89 mm | 11.03 mm | 75.11 mm | 47.85 mm | 5.86 mm | 10.64 mm |
| Cash remaining | 44.65 mm | 40.51 mm | -23.57 mm | 3.69 mm | 45.68 mm | 40.90 mm |
| Runway (months of cash) | 14.4 | 8.2 | -0.7 | 0.2 | 17.3 | 8.5 |
Institutional ownership, Q4 2022
51.7% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 52 |
| Opened positions | 4 |
| Closed positions | 10 |
| Increased positions | 12 |
| Reduced positions | 16 |
| 13F shares | Current |
|---|---|
| Total value | 6.87 bn |
| Total shares | 22.26 mm |
| Total puts | 68.50 k |
| Total calls | 80.40 k |
| Total put/call ratio | 0.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Telemus Capital | 7.40 mm | $4.19 bn |
| Highbridge Capital Management | 2.89 mm | $0.00 |
| Renaissance Technologies | 1.95 mm | $1.02 mm |
| D. E. Shaw & Co | 1.89 mm | $12.30 mm |
| MintBroker International | 1.40 mm | $7.21 mm |
| D. E. Shaw & Co. | 1.21 mm | $630.23 mm |
| Vanguard | 741.82 k | $386.34 mm |
| Staley Capital Advisers | 615.15 k | $320.00 k |
| BLK Blackrock | 573.68 k | $298.77 mm |
| LSV Asset Management | 390.35 k | $203.00 k |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Nov 22 | John C Chapman | Common Stock | Buy | Acquire P | No | No | 0.51 | 20,000 | 10.20 k | 174,324 |
| 10 Nov 22 | Crew Timothy C | Common Stock | Buy | Acquire P | No | Yes | 0.48 | 15,000 | 7.20 k | 604,291 |
| 10 Nov 22 | Lepore Patrick G | Common Stock | Buy | Acquire P | No | No | 0.49 | 100,000 | 49.00 k | 587,145 |
| 14 Sep 22 | Melissa Rewolinski | Common stock | Buy | Acquire P | No | No | 0.49 | 31,159 | 15.27 k | 93,259 |
| 7 Sep 22 | Abt John | Common Stock | Payment of exercise | Dispose F | No | No | 0.47 | 950 | 446.50 | 118,825 |
News
NYSE To Suspend Trading Immediately In Lannett Co And Commence Delisting Proceedings
20 Apr 23
NYSE To Suspend Trading Immediately In Lannett Co., Commence Delisting Proceedings
19 Apr 23
Stocks That Hit 52-Week Lows On Friday
14 Apr 23
Stocks That Hit 52-Week Lows On Thursday
13 Apr 23
12 Health Care Stocks Moving In Tuesday's Intraday Session
4 Apr 23